ProfileGDS4132 / 238513_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 1% 1% 2% 1% 2% 2% 1% 2% 3% 1% 2% 3% 3% 5% 3% 4% 5% 13% 3% 5% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 1019.103611
GSM201543Muscle PCOS pioglitazone 1219.391941
GSM201544Muscle PCOS pioglitazone 1619.913962
GSM201545Muscle PCOS pioglitazone 2018.55011
GSM201829Muscle PCOS pioglitazone 23110.89792
GSM201830Muscle PCOS pioglitazon 25111.06442
GSM201831Muscle PCOS pioglitazone 27110.7361
GSM201832Muscle PCOS pioglitazone 3110.76442
GSM201833Muscle PCOS pioglitazone 419.94963
GSM201834Muscle PCOS pioglitazone 819.477111
GSM201835Muscle PCOS after pioglitazone 1029.498172
GSM201836Muscle PCOS after pioglitazone 1229.016973
GSM201837Muscle PCOS after pioglitazone 1628.922043
GSM201838Muscle PCOS after pioglitazone 20210.8095
GSM201839Muscle PCOS after pioglitazone 23211.00423
GSM201840Muscle PCOS after pioglitazone 25210.99824
GSM201841Muscle PCOS after pioglitazone 27211.94815
GSM201842Muscle PCOS after pioglitazone 3219.375613
GSM201843Muscle PCOS after pioglitazone 4210.14273
GSM201844Muscle PCOS after pioglitazone 8211.98115